SLFN12 and neoplasm: The survival curves suggest that a low SLFN12 expression in the tumor is associated with a poor prognosis for SLFN12 alone as well as for all of the gene signatures identified, with better survival prediction capabilities for the SLFN12 gene signature than for SLFN12 alone.